Scientists from US biotech company eGenesis and Harvard Medical School say that trials could pave the way for better outcomes for ‘countless individuals’ in need of transplants.
Scientists from US biotech company eGenesis and Harvard Medical School say that trials could pave the way for better outcomes for ‘countless individuals’ in need of transplants.